Advertisement
Advertisement
U.S. markets open in 4 hours 57 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX Delayed Price. Currency in AUD
3.1000-0.0300 (-0.96%)
At close: 04:10PM AEDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in AUD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/27/2023
Current
Market Cap (intraday)
607.52M
Enterprise Value
843.53M
Trailing P/E
3.40
Forward P/E
13.12
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
0.61
Price/Book (mrq)
2.61
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
2.33

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-37.65%
S&P500 52-Week Change 3-8.95%
52 Week High 35.8800
52 Week Low 32.8650
50-Day Moving Average 33.0810
200-Day Moving Average 34.0880

Share Statistics

Avg Vol (3 month) 3716.14k
Avg Vol (10 day) 3642.84k
Shares Outstanding 5201.83M
Implied Shares Outstanding 6N/A
Float 8120.38M
% Held by Insiders 18.02%
% Held by Institutions 160.22%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.82
Forward Annual Dividend Yield 426.89%
Trailing Annual Dividend Rate 30.53
Trailing Annual Dividend Yield 316.93%
5 Year Average Dividend Yield 4N/A
Payout Ratio 413.57%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 23, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2022
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 17.90%
Operating Margin (ttm)27.52%

Management Effectiveness

Return on Assets (ttm)30.79%
Return on Equity (ttm)113.46%

Income Statement

Revenue (ttm)995.6M
Revenue Per Share (ttm)4.95
Quarterly Revenue Growth (yoy)39.20%
Gross Profit (ttm)762.63M
EBITDA 286.36M
Net Income Avi to Common (ttm)178.24M
Diluted EPS (ttm)0.8800
Quarterly Earnings Growth (yoy)1,355.50%

Balance Sheet

Total Cash (mrq)27.51M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)262.38M
Total Debt/Equity (mrq)112.82
Current Ratio (mrq)0.63
Book Value Per Share (mrq)1.16

Cash Flow Statement

Operating Cash Flow (ttm)284.09M
Levered Free Cash Flow (ttm)250.39M
Advertisement
Advertisement